Clinical Trials List
2024-09-01 - 2031-08-31
Phase III
Recruiting6
ICD-10L73.2
Hidradenitis suppurativa
ICD-9705.83
Hidradenitis
-
Trial Applicant
AbbVie
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yun-Ting Chang Division of Dermatology
- DINGDAR LEE Division of Dermatology
- 馬聖翔 Division of Dermatology
- Cheng-Yuan Li Division of Dermatology
- 吳貞宜 Division of Dermatology
- 張綜顯 Division of Dermatology
- 何翊芯 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- TSEN-FANG TSAI Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳南霖 Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Huei Huang Division of Dermatology
- Chun-Wei Lu Division of Dermatology
- 吳吉妮 Division of Dermatology
- Chun-Bing Chen Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林尚宏 Division of Dermatology
- 鄭裕文 Division of Dermatology
- Chih-Hung Lee Division of Dermatology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
1280 participants
